Journal Home
Search for

Articles in Press

Return to articles in press list

Altered mental status from acyclovir

Gabriel J. Martinez-Diaz, BS, Renee Hsia, MD, MSCCorresponding Author Information

Received 16 April 2009; received in revised form 28 June 2009; accepted 10 August 2009. published online 19 November 2009.
Corrected Proof

Abstract— 

Background: Acyclovir is widely used in the treatment of herpes virus infections, particularly herpes simplex virus and varicella-zoster virus. Acyclovir, when given promptly upon the start of a herpes zoster eruption, speeds healing and diminishes acute pain. Objectives: Because acyclovir is a commonly used medication, it is crucial for health providers to be aware of appropriate dosing as well as possible side effects. We present this case to increase awareness of the potential for inappropriate dosing of acyclovir and the presentations of patients with toxic effects. Case Report: We report the case of a 65-year-old man with a past medical history significant for chronic kidney disease who presented to the Emergency Department with progressive confusion and ataxia over 2 days. Thorough questioning in the patient's native language revealed that he had recently started a medication for a “rash.” Neither he nor his family knew the name of the new medication; further investigation revealed it to be acyclovir. Although other diagnoses were considered in the differential diagnosis for this patient with altered mental status, he was treated for presumed acyclovir toxicity and given prompt dialysis, upon which his symptoms resolved. Conclusion: It is important for physicians to remember that even common medications such as acyclovir can have serious side effects and complications. In this case, renal dosing was not used in a patient on hemodialysis. Acyclovir must be renally dosed and carefully monitored through drug level measurement in patients with limited kidney function to prevent serious side effects, such as the neurological sequelae demonstrated in this case report. Emergency physicians should be aware of the potential for inappropriate dosing of this medication and the presentations of patients with toxic effects.

 Stanford University School of Medicine, Stanford, California

 Department of Emergency Medicine, San Francisco General Hospital, University of California at San Francisco, San Francisco, California

Corresponding Author InformationReprint Address: Renee Hsia, MD, MSC, Department of Emergency Medicine, San Francisco General Hospital, University of California at San Francisco, 1001 Potrero Hill, SFGH - NH-1E21, San Francisco, CA 94110

PII: S0736-4679(09)00781-1

doi:10.1016/j.jemermed.2009.08.048